evidencegaps
Primary study · included by 1 review

Association Between Systemic Lupus Erythematosus and Cancer Morbidity and Mortality: Findings From Cohort Studies.

Zhang 2022 · Zhang Min, Wang Yizhou, Wang Yutong, et al. · Frontiers in oncology · 2022

Included by

Bladder cancer risk factors: a comprehensive umbrella review of meta-analyses.
Non-Cochrane · aetiology · 2026 · cited as Zhang 2022 · Table 1 (Included MA); References
Outcome this study informsPooled effectEvidenceCertainty
Secondary bladder cancer
With primary colorectal cancer vs Without primary colorectal cancer
RR 1.19 [1.06, 1.33]7 studies · 42880 participantsVery low
Risk of bladder cancer
With lupus erythematosus vs Without lupus erythematosus
RR 1.66 [1.07, 2.59]12 studies · 2806175 participantsVery low

1 including review in total.